INTRODUCTION
The decrease in bone volume associated with osteoporosis and age-related osteopenia is accompanied by an increase in marrow adipose tissue 15) . Indeed, an increase in marrow adipocytes is observed in all conditions that lead to bone loss, such as ovariec-tomy 23) , immobilization 13) , or treatment with glucocorticoids 22) . With age, the number and size of marrow adipocytes increased in a linear manner 20) . One mechanism that could account for the apparent reciprocal relationship between decreased bone density and increased fat formation is an imbalance in the production of bone-forming and fat-forming cells in the marrow cavity 15) . Bone marrow contains mesenchymal progenitor cells that have multiple differential potentials. Mesenchymal stem cells have the potential to differentiate into osteoblasts, adipocytes, chondrocytes, and myoblasts 7, 19) . In vitro and in vivo experimental models have provided substantial evidence for the reciprocal relationship between cell lineages. Previous studies have provided evidence that cultures of bone marrow stromal cells are capable of both osteogenic and adipocytic differentiation 16, 17) . In a mouse model of accelerated aging, the SAMP 6 strain, osteoblastogenesis is decreased and there is a concordant increase in the number of marrow adipocytes 11) . These evidences of the transdifferentiation suggest that a large degree of plasticity exists between osteoblasts and adipocytes.
Therefore, it is possible that inhibition of marrow adipogenesis with a concomitant increase in osteoblastogenesis could provide a therapeutic target with which to either prevent further increase in adipocytes formation or divert existing adipocytes to become more osteoblastic with a resulting increase in functional bone mass. In this study, the effects of some drugs on the transdifferentiation of adipocyte and osteoblast were investigated using pre-adipocyte and pre-osteoblast cell lines.
MATERIALS AND METHODS

Cell culture&differentiation
3T3-L1 preadipocytes were purchased from the American Type Tissue Collection, and mouse preosteoblast-like cell line, KS483, was kindly supplied by Dr. Hyun-Mo Ryoo (Department of Oral Biochemistry, School of Dentistry, Kyungpook National University, Daegu).
Cells were grown to confluence with standard medium (DMEM containing 10% fetal bovine serum, 100 U/mL penicillin, 0.1 mg/mL streptomycin, and 0.25 g/mL amphotericin B) in 75 cm 2 culture flask as described by Park et al.
18)
. For the induction of adipogenesis, confluent cells were stimulated to differentiate by supplementing standard medium with 1 M dexamethasone, 10 g/mL insulin, and 0.5 mM isobutylmethylxanthine for 3 days. The medium was then replaced with standard medium containing 5 g/mL insulin 18) . Osteogenesis was induced by supplementing standard medium with 50 g/mL ascorbic acid and 10 mM-glycerophosphate. Culture medium was changed every 2 days and the cells were used for experiments at 10 days after confluence.
Lipoprotein Lipase (LPL) and Alkaline Phosphatase (AP) activity assay
At the end of experiment, medium was harvested for LPL activity assay. Cells were rinsed with ice-cold phosphate-buffered saline, harvested with 0.5 mL of MNT-buffer (20 mM 2-(Nmorpholino) ethanesulfonic acid, 100 mM NaCl, 30 mM Tris, and 1 mM CaCl2, pH 7.6) containing 1% Triton X-100 18) , and sonicated briefly at 4℃ The suspension was centrifuged at 15,000×g for 20 min at 4℃, and the infranatant was used for AP activity assay.
For LPL activity assay, a stock triacylglycerol emulsion containing 5 mCi of tri [9, 10 (n)- . Before assay, 1 vol. of stock emulsion, 19 vol. of 3% bovine serum albumin in 0.2 M Tris-HCl buffer (pH 8.1) and 5 vol. of heat-inactivated fasted rat serum (heated at 60℃ for 30 min) were mixed and incubated for 30 min. For assay, 100 L of this activated substrate mixture was added to a same amount of enzyme solution, and incubated at 37℃ for 60 min. Released fatty acids were extracted and measured as described previously 14) . One mU of LPL activity represents the release of 1 nmol of fatty acid/min. AP activity was measured using p-nitrophenyl phosphate as the substrate 5) . The reaction mixture containing 0.5 M Tris-HCl, pH 9.0, 0.5 mM p-nitrophenyl phosphate, 0.5 mM MgCl2 and enzyme solution was incubated at 37℃ for 30 min. The reaction was stopped by the addition of 0.25 volume of 1 N NaOH. Hydrolysis of p-nitrophenyl phosphate was monitored at changes of optical density at 410 nm. p-Nitrophenol was used as a standard. The unit of AP activity was expressed as the release of 1 nmol of p-nitrophenol/min.
Oil Red O and AP activity staining
Lipid droplets of cells were stained with Oil Red O according the method of Strutt et al. 21) . The cells were washed with HBSS and fixed overnight with 10% formalin at room temperature.
After rinsing with 60% isopropanol for 30 sec, cells were stained with Oil Red O for 1 hour. Stained cells were rinsed with 60% isopropanol for about 5 sec while shaking gently.
Cells were stained for AP activity as described in the instruction manual of AP staining kit (Sigma Chemical Co.). Briefly, the adherent cell layer was washed with cold PBS, fixed in citrate-buffered acetone (60%) for 30 sec, and washed with distilled water. The cultures were then incubated for 30 min at room temperature with naphtol AS-MX phosphate as substrate, in the presence of Fast Violet B salt. After counterstaining in hema-LPL Activity (%) .
RESULTS
3T3-L1, a murine preadipocytes, and KS483 cells, a murine preosteoblast-like cell line, were grown to confluence, and began to culture in either adipogenic or osteogenic conditions for 10 days. LPL activity only in 3T3-L1 cells cultured in adipogenic conditions, and AP activity only in KS483 cells cultured in osteogenic medium were greatly increased (Fig. 1) . Slight increases of LPL activity in 3T3-L1 cells cultured under the osteogenic conditions, and AP activities of both cells cultured under the adipogenic conditions were also observed. However, the degree of increase was much smaller than that in normally differentiated cells. At first, both cells showed the similar fibroblast-like morphology. However, after differentiation, cells became larger and ovoid. Numerous lipid droplets in the cytosol were observed in adipocytes (Fig. 2) . The changes of LPL and AP activities were well correlated with the accumulation of lipid droplets stained with Oil Red O and AP activity staining, respectively (Fig. 3) .
To investigate the effect of various drugs on the differentiation of both cells, cells were induced to differentiate in either adipogenic or osteogenic conditions for 10 days in the presence of dexamethasone, retinoic acid or vitamin D. Dexamethasone (10 -7 M) itself did not cause any significant alterations on the induction of LPL and AP in both cell lines except slight increase of AP activity in KS483 cells grown under osteogenic medium (Fig. 4) . In the presence of 10 -7 M retinoic acid during the differentitation, AP activities were significantly increased in all the differentiation conditions. Especially, both cells in adipogenic medium and KS483 cells cultured in adipogenic medium were greatly increased. However, no alterations in LPL activity was observed in both cell lines (Fig. 5) . The effects of vitamin D (10 -8 M) on AP activity of KS483 cells were not prominent. Rather, AP activity was somewhat decreased in KS483 cells dif- ferentiated in osteogenic medium. However, its effect on 3T3-L1 cells was significant. Cellular AP activity was greatly increased while LPL activity was significantly inhibited (Fig. 6 ). AP Activity (%) AP Activity (%) 
DISCUSSION
Bone marrow is believed to contain multipotent stromal fibroblastic stem cells that can differentiate into fibroblastic, osteogenic, adipogenic and reticular cells 6, 7) . Stem cells generate progenitors committed to one or more cell line with an apparent degree of plasticity or interconversion 15) . However, complete knowledge concerning the control and modulation of the specific differentiation steps throughout the osteogenic, adipogenic and associated cell lineages and the phenotype and functional characteristics of the cellular progenitors is still lacking.
Various markers have been used for the evaluation of differentiation into adipocytes or osteoblasts. In this study, we chose LPL activity and the content of lipid droplets demonstrated by Oil Red O staining for the indicators of adipocyte differentiation. Formation of lipid droplet in the cytoplasm is the critical hallmark for the differentiation into adipocytes. Accumulation of lipid was always preceded by the increase of cellular LPL activity. LPL is an acylglycerol hydrolase (EC 3.1.1.34) that hydrolyzes the triglyceride component of circulating chylomicron and very low density lipoprotein (VLDL) into two fatty acids and monoacylglycerol 2) . The enzyme is found in extrahepatic tissues including adipose tissues, cardiac and skeletal muscles, lactating mammary gland, lung, spleen, and brain 3) , where it catalyzes the ratelimiting step for lipid acquisition from circulating triglycerides. The deficiency or dysfunction of LPL has been found in association with the pathogenesis of hypertriglyceridemia 8) . AP (EC 3.1.3.1) is a membrane bound enzyme that hydrolyzes phosphomonoester bond contained in various organic compounds. They are abundant in bone, liver, kidney, intestine, and placenta. In bone tissue, AP activity is associated with osteoblastic differentiation 4, 5) . High AP activity is generally considered as one of the early markers in the maturation of osteoblast compared to osteocalcin and osteopontin which peak later 25) . For the evaluation of differentiation into osteoblast, AP activity was chosen as a marker in this study.
The established cell lines most frequently used as models for studies on osteoblast or adipocyte differentiation are of two types; fibroblastic multipotent cell lines that have not been committed to the adipose or osteoblastic lineage and preadipocyte or preosteoblast cell lines that have undergone such commitment 9, 12) . KS-483 is the preosteoblast cell line subcloned from mouse osteoblastic KS-4 cell that was isolated from mouse calvaria 24) . Original KS-4 cells were not necessarily stable, with unexpected phenotypic and morphological changes often observed after passage 10. The stability of KS-483 cell line was greatly improved and it is somewhat differentiated preosteoblast cell line in terms of AP activity, osteocalcin production and calcified nodule formation.
3T3-L1 cell line, subcloned from Swiss 3T3 cells, is one of the most frequently used preadipocyte cell lines. When preadipocytes were treated with specific inducers such as insulin, isobutylmethylxanthine and dexamethasone, they undergo two or three rounds of cell division, become growth-arrested, and then coordinately express adipocyte genes 10) . In this study, we tried to investigate the effect of some drugs on the transdifferentiation of pre-adipocyte and pre-osteoblast cells. When 3T3-L1 and KS483 cells were induced to differentiate in either adipogenic or osteogenic conditions, adipogenesis occurred only in 3T3-L1 cells cultured in adipogenic conditions, and osteogenesis occurred only in KS483 cells cultured in osteogenic medium ( Fig. 1-3 ). These results suggest that the fates of both cell lines in differentiation lineage have been already determined.
However, the terminal differentiation of these committed cells could be modulated by the treatment with various drugs. Differentiation of 3T3-L1 cells into adipocyte was significantly inhibited by vitamin D treatment, while the osteogenesis was greatly enhanced as evidenced by the increase of cellular AP activity. Effect of vitamin D on KS483 cell differentiation was not so prominent as the inhibition of adipogenesis. In the case of retinoic acid, AP activities were significantly increased in all the differentiation conditions. However, no alterations in LPL activity was observed in both cell lines. These results suggest that even though these cells might have a phenotype characterized by markers of differentiation, transdifferentiation of these cells could still occur.
Even though further studies on the other specific markers are needed, our results indicate that commitment to either lineage, as characterized by osteoblastic-and adipogenic-specific gene and enzyme activities, does not necessarily mean that cells are lost to therapeutic manipulation. The inhibition of marrow adipogenesis and concomitant increase in osteoblastogenesis may provide a potential novel approach to increase bone formation and therefore, as a standard therapy or in combination with an antiresorptive therapy, may provide more efficacious prevention or treatment of osteopenic disorders.
SUMMARY
The decrease in bone volume associated with osteoporosis and
